Vancomycin resistance VanS/VanR two-component systems

Advances in Experimental Medicine and Biology

Volumn 631, Issue , 2008, Pages 200-213

  Hong, Hee Jeon ^a   Hutchings, Matthew I ^b   Buttner, Mark J ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c JOHN INNES CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

A47934; ANTIBIOTIC AGENT; BAMBERMYCIN; GAMMA GLUTAMYLTRANSFERASE; TEICOPLANIN; UNCLASSIFIED DRUG; VANCOMYCIN; BACTERIAL PROTEIN; PEPTIDYLTRANSFERASE; PROTEIN KINASE; TRANSCRIPTION FACTOR; VANR PROTEIN, BACTERIA; VANS PROTEIN, ENTEROCOCCUS;

ACTINOBACTERIA; ACTINOPLANES TEICHOMYCETICUS; AMYCOLOTOPSIS ORIENTALIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; DRUG STRUCTURE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GENE CLUSTER; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOMYCES COELICOLOR; STREPTOMYCES TOYOCAENSIS; AMINO ACID SEQUENCE; BACTERIAL GENE; BACTERIAL INFECTION; CHEMISTRY; DRUG EFFECT; ENTEROCOCCUS; GENETICS; HUMAN; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; MULTIGENE FAMILY; PATHOGENICITY; PHYSIOLOGY; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

ACTINOBACTERIA (CLASS); ACTINOPLANES TEICHOMYCETICUS; AMYCOLATOPSIS ORIENTALIS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; STAPHYLOCOCCUS AUREUS; STREPTOMYCES COELICOLOR; STREPTOMYCES TOYOCAENSIS;

ACTINOBACTERIA; AMINO ACID SEQUENCE; BACTERIAL PROTEINS; ENTEROCOCCUS; GENES, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; PEPTIDYL TRANSFERASES; PROTEIN KINASES; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; TEICOPLANIN; TRANSCRIPTION FACTORS; VANCOMYCIN RESISTANCE;

EID: 55949115607     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-78885-2_14     Document Type: Review

References (59)

1. Williams DH. Williamson MP. Butcher DW et al, Detailed binding sites of the antibiotics vancomycin and ristocetin A: determination of intermolecular distances in antibiotic/substrate complexes by use of the time-dependent NOE. J Am Chern Soc 1983; 105:1332-1339.
2. Barna JCJ, Williams DH. The structure and mode of action ofglycopeptide antibiotics of the vancomycin group. Annu Rev Microbiol1984; 38:339-57.
3. Bugg TDH, Wright GD, Dutka-Malen S et aI. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depslpepnde peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. Biochemistry 1991; 30:10408-10415.
4. Healy VL, Lessard IA. Roper DI er aI. Vancomycin resistance in enterococci: reprogramming of the D-Ala-D-Ala ligases in bacterial peptidoglycan biosynthesis. Chern Bioi 2000; 7:RI09-II9.
5. Walsh CT, Fisher SL, Park IS et aI. Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story. Chern Bioi 1996; 3:21-8.
6. Pootoolal J, Neu J, Wright GD. Glycopeptide antibiotic resistance. Annu Rev Pharmacol Toxicol 2002; 42:381-408.
7. Weigel, LM, Clewell DB, Gill SR et aI. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 2003; 28: I569-1571.
8. Pearson, H. 'Superbug' hurdles key drug barrier. Nature 2002; 418:469-470.
9. Chang S, Sievert DM, Hageman JC et aI. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003; 348: 1342-1347.
10. Tenover FC, Weigel LM, Appelbaum PC et al. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother 2004; 48:275-280.
11. Arthur M, Quintiliani R. Regulation of VanA- and VanB-type glycopeptide resistance in enterococci. Antimicrob Agents Chemother 2001; 45:375-81.
12. Reynolds PE, Courvalin P. Vancomycin resistance in enterococci due to synthesis ofprecursors terminating in D-alanyl-D-serine. Antimicrob Agents Chernother 2005; 49:21-5.
13. Billot-Klein D, Blanot D, Gutmann L et aI. Association constants for the binding of vancomycin and teicoplanin to N-acetyl-D-alanyl-D-alanine and N-acetyl-D-alanyl-D-serine. Biochem J 1994; 304:1021-1022.
14. Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science 1994; 264:375-382.
15. Pootoolal J, Thomas MG, Marshall CG er aI. Assembling the glycopeptide antibiotic scaffold: the biosynthesis of A47934 from Streptomyces toyocaensis. Proc Natl Acad Sci USA 2002; 99:8962-8967.
16. Sosio M, Kloosterman H, Bianchi A et aI. Organization of the teicoplanin gene cluster in Actinoplanes teichomyceticus. Microbiology 2004; 150:95-102.
17. Serina S. Radice F, Maffioli S ct aI. Glycopeptide resistance determinants from the teicoplanin producer Actinoplanes teichomyceticus. FEMS Microbiol Lett 2004; 240:69-74.
18. Beltrametti F, Consolandi A, Carrano L et al. Resistance to glycopeptide antibiotics in the teicoplanin producer is mediated by van-gene homologue expression directing the synthesis of a modified cell wall peptidoglycan. Antimicrob Agents Chemother 2007; 51:II35-41.
19. Arthur M, Depardieu F, Cabanie L et aI. Requirement of the VanY and VanX D,D-peptidases for glycopeptide resistance in enterococci. Mol Microbiol1998; 30:819-30.
20. Wright GD, Molinas C, Arthur M er aI. Characterization of VanY, aDD-carboxypeptidase from vancomycin-resistant Enterococcus faecium BM4147. Antimicrob Agents Chemother 1992; 36:1514-8.
21. Arthur M, Depardieu F, Molinas C et aI. The vanZ gene ofTnl546 om Enterococcus faecium BM4147 confers resistance to teicoplanin. Gene 1995; 154:87-92.
22. Hong H-J, Hutchings MI, Neu JM et aI. Characterisation of an inducible vancomycin resistance system in Streptomyces coelicolor reveals a novel gene (vanK) required for drug resistance.Mol Microbiol 2004; 52:II07-II21.
23. Hong H-J. Hutchings MI, Hill LM et aI. The role of the novel Fern protein YanK in vancomycin resistance in Streptomyces coelicolor. J Bioi Chern 2005; 280:13055-13061.
24. Wright GD. Holman TR. Walsh CT. Purification and characterization of VanR and the cytosolic domain of VanS: a two-component regulatory system required for vancomycin resistance in Enterococcus faecium BM4147. Biochemistry 1993; 32:5057-63.
25. B G2 ATP-binding motif, leads to constitutive glycopeptide resistance in VanB-type Enterococcus faecium. Mol Microbiol2003; 50:1069-1083.
26. Hutchings MI, Hong H-J, Buttner MJ. The vancomycin resistance VanS/VanR two-component signal transduction system of Streptomyces coelicolor. Mol Microbiol 2006; 59:923-935.
27. Holman TR, Wu Z, Wanner BL et aI. Identification of the DNA-binding site for the phosphorylated VanR protein required for vancomycin resistance in Enterococcus faecium Biochemistry 1994; 33:4625-31.
28. Depardieu F, Courvalin P, Kolb A. Binding sites of VanR. and a70 RNA polymerase in the vanB vancomycin resistance operon of Enterococcus faecium BM4524. Mol Microbiol 2005; 57:550-64.
29. Arthur M, Depardieu F, Gerbaud G et aI. The VanS sensor negatively controls VanR-mediated transcriptional activation of glycopeptide resistance genes of Tn1546 and related elements in the absence of induction. J Bacteriol 1997; 179:97-106.
30. Haldimann A, Fisher SL, Daniels LL et aI. Transcriptional regulation of the Enterococcus faecium BM4147 vancomycin resistance gene cluster by the VanS-VanR two-component regulatory system in Escherichia coli K-12. J Bacteriol1997; 179:5903-5913.
31. Baptista M, Rodrigues P, Depardieu F et aI. Single-cellanalysisof glycopeptide resistance gene expression in teicoplanin-resisrant mutants of a VanB-type Enterococcus faecalis. Mol Microbiol1999; 32:17-28.
32. Comenge Y, ~intiliani R Jr, Li L et aI. The CroRS two component regulatory system is required for intrinsic beta-lactam resistance in Enterococcus faecalis. J Bacteriol 2003; 185:7184-92.
33. Mascher T. Intramembrane-sensing histidine kinases: a new family of bacterial cell envelope stress sensors. FEMS Microbiol Lett 2006; 264:133-144.
34. Ulijasz AT, Grenader A, Weisblum B. A vancomycin-inducible lacZ reporter system in Bacillus subtilis. induction by antibiotics that inhibit cell wall synthesis and by lysozyme. J Bacteriol 1996; 178:6305-6309.
35. Arthur M, Depardieu F, Courvalin P. Regulated interactions between partner and nonpartner sensors and response regulators that control glycopeptide resistancegene expression in enterococci. Microbiology 1999; 145:1849-58.
36. Lai MH, Kirsch DR. Induction signals for vancomycin resistance encoded by the vanA gene cluster in Enterococcus faecium. Antimicrob Agents Chemother 1996; 40:1645-1648.
37. Mani N, Sancheti P, Jiang ZD et aI. Screening systems for detecting inhibitors of cell wall transglycosylation in Enterococcus. Cell wall transglycosylation inhibitors in Enterococcus. J Antibiot 1998; 51:471-479.
38. Grissom-Arnold J, Alborn WE, Nicas TI et aI. Induction of VanA vancomycin resistance genes in Enterococcus faecalis: use of a promoter fusion to evaluate glycopeptide and nonglycopeptide induction signals. Microbial Drug Resistance 1997; 3:53-64.
39. Baptista M, Depardieu F, Courvalin P et aI. Specificity of induction of glycopeptide resistance genes in Enterococcus faecalis. Antimicrob Agents Chemother 1996; 40:2291-2295.
40. Allen NE, Hobbs IN. Induction of vancomycin resistance in Enterococcus faecium by nonglycopeptide antibiotics. FEMS Microbiol Lett 1995; 132:107-114.
41. Handwerger S, Kolokathis A. Induction of vancomycin resistance in Enterococcus faecium by inhibition of transglycosylation. FEMS Microbiol Lett 1990; 58:167-170.
42. van Heijenoort J. Formation of the glycan chains in the synthesis of bacterial peptidoglycan. Glycobiology 2001; 11:25R-36R.
43. Chen L, Walker D, Sun B. et aI. Vancomycin analogues active against vanA-resistant strains inhibit bacterial transglycosylasewithout binding substrate. Proc Natl Acad Sci USA 2003; 100:5658-5663.
44. Baptista M, Depardieu F, Reynolds P et aI. Mutations leading to increased levels of resistance to glycopeptide antibiotics in VanB-type enterococci. Mol Microbiol1997; 25:93-105.
45. Neu JM, Wright GD. Inhibition of sporulation, glycopeptide antibiotic production and resistance in Streptomyces toyocaensis NRRL 15009 by protein kinase inhibitors. FEMS Microbiol Lett 2001; 199:15-20.
46. Dong SD, Oberthur M, Losey HC et aI. The structural basis for induction ofVanB resistance. J Am Chern Soc 2002; 124:9064-5.
47. Sharman GJ, Try AC, Dancer RJ et al. The roles of dimerization and membrane anchoring in activity of glycopeptide antibiotics against vancomycin-resistant bacteria. J Am Chern Soc 1997; 119:12041-12047.
48. Cooper MA, Williams, DH. Binding of glycopeptide antibiotics to a model of a vancomycin-resistant bacterium. Chern Biol 1999; 6:891-899.
49. Beauregard DA, Williams DH, Gwynn MN et aI. Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics. Antimicrob Agents Chemother 1995; 39:781-785.
50. Ge M, Chern Z, Onishi HR er aI. Vancomycinderivativesthat inhibit peptidoglycan biosynthesiswithout binding D-A1a-D-A1a. Science 1999; 284:507-511.
51. Sinha Roy R, YangP, Kodali S et aI. Direct interaction of a vancomycin derivativewith bacterial enzymes involved in cell wall biosynthesis. Chern BioI 2001; 8:1095-1106.
52. Kerns, R. Dong, S.D. Fukuzawa S et aI. The Role of hydrophobic substiruents in the biological activity of glycopeptide antibiotics J Am Chern Soc 2000; 122:12608-12609.
53. Billet-Klein D, Gutmann L, Sable S et al. Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VANB-type Enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides and Enterococcus gallinarum. J Bacreriol 1994; 176:2398-405.
54. Biller-Klein D. Legrand R, Schoot B et al. Peptidoglycan structure of Lactobacillus casei, a species highly resistant to glycopeptide antibiotics. J Bacterioll997; 179:6208-12.
55. Handwerger S. Pucci MJ, Volk KJ et al. Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic peptidoglycan precursors that terminate in lactate. J Bacteriol 1994; 176:260-4.
56. Nicas TI, Cole CT. Preston DA et al. Activity ofglycopeptides against vancomycin-resistant Gram-positive bacteria. Antimicrob Agents Chemother 1989; 33:1477-8l.
57. 57. Gutmann L. al-Obeid S. Billot-Klein D ct al. Synergy and resistance to synergy between β-Iaetam antibiotics and glycopeptides against glycopeptide-resistant strains of Enterococcus faecium. Antimicrob Agents Chemother 1994; 38:824-9.
58. Severin A, Wu SW; Tabei K et al. Penicillin-binding protein 2 is essential for expression of high-level vancomycin resistance and cell wall synthesis in vancomycin-resistant Staphylococcus aureus carrying the enterococcal vanA gene complex. Antimicrob Agents Chemother 2004; 48:4566-73.
59. Severin A. Tabei K. Tenover F et al. High level oxacillin and vancomycin resistance and altered cell wall composition in Staphylococcus aureus carrying the staphylococcal mecA and the enrerococcal vanA gene complex. J BioI Chem 2004; 279:3398-3407.